MIR4639: A Drug Target / Disease Biomarker (G100616269)
MIR4639: A Drug Target / Disease Biomarker
MIR4639, also known as interleukin-4639, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the interleukin-4 family, which includes several other proteins that play important roles in immune and inflammatory responses. MIR4639 has been shown to have several potential drug targets and may be a promising biomarker for several types of cancer.
One of the key functions of MIR4639 is its role in the immune response. MIR4639 is a type of immune cell surface receptor, which allows it to interact with other immune cells and trigger an immune response. This interaction between MIR4639 and its ligands is critical for the regulation of immune responses and is a key step in the development of cancer.
In addition to its role in the immune response, MIR4639 has also been shown to play a key role in the regulation of cell signaling pathways that are involved in the development of cancer. For example, MIR4639 has been shown to promote the growth and survival of cancer cells, and it has been shown to inhibit the apoptosis (programmed cell death) of cancer cells.
MIR4639 has also been shown to play a role in the regulation of inflammation, which is a key factor in the development of many types of cancer. For example, MIR4639 has been shown to promote the recruitment of immune cells to the site of an inflammatory reaction, which is important for the regulation of immune responses and the development of cancer.
In conclusion, MIR4639 is a protein that has been shown to play a key role in several important biological processes that are involved in the development of cancer. As a result, MIR4639 is a potential drug target and may be a useful biomarker for the diagnosis and treatment of cancer. Further research is needed to fully understand the role of MIR4639 in the immune and inflammatory responses and to determine its potential as a drug.
Protein Name: MicroRNA 4639
The "MIR4639 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4639 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742
